trapidil has been researched along with Ischemic Attack, Transient in 2 studies
Trapidil: A coronary vasodilator agent.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, S | 2 |
| Sobata, E | 2 |
| Ando, A | 1 |
| Iwabuchi, T | 2 |
2 other studies available for trapidil and Ischemic Attack, Transient
| Article | Year |
|---|---|
[Possible role of microthrombus in the pathogenesis of cerebral vasospasm (author's transl)].
Topics: Adult; Aged; Cerebral Arteries; Epoprostenol; Female; Humans; Intracranial Aneurysm; Intracranial Em | 1982 |
Prevention of cerebral ischemic symptoms in cerebral vasospasm with trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2.
Topics: Adult; Aged; Cerebral Angiography; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient | 1981 |